The DIAMA project is assessing and validating the Deeplex® Myc-TB test in Africa and Europe. This rapid molecular test (based on mass sequencing) detects and genotypes mycobacteria and predicts antituberculosis drug resistance in Mycobacterium tuberculosis complex strains.
Partners:
- Centre National Hospitalier de Pneumo-Phtisiologie - Benin,
- Prins Leopold Instituut voor Tropische Geneeskunde - Belgium (Bruxelles),
- Université des Sciences, des Techniques et des Technologies de Bamako (USTTB) - Mali,
- London School of Hygiene and Tropical Medicine (LSHTM) - United Kingdom (London),
- Service de Pneumophtisiologie de l’Hôpital National Ignace Deen - Guinea,
- Jimma University - Ethiopia,
- Université Catholique de Louvain (UCL) - Belgium (Louvain),
- The Bamenda Center for Health Promotion and Research - Cameroun,
- Institute National of Research Biomedical of Zaire (INRB) - Congo,
- Damien Foundation - Belgium (Bruxelles),
- Rwanda Biomedical Center (RBC) - Rwanda,
- University Cheikh Anta Diop - Senegal,
- World Health Organization (WHO).
Funding:
